Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has maintained an Overweight rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $88 to $95.
January 12, 2024 | 3:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Merit Medical Systems' stock may see a positive short term impact due to Piper Sandler's increased price target from $88 to $95 with an Overweight rating maintained.
Analyst ratings and price target adjustments are significant indicators for investors. The increase in price target by Piper Sandler suggests a bullish outlook on Merit Medical Systems, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100